10X Genomics (TXG) PT Raised to $47 at Piper Sandler
Tweet
Share
E-mailGet Alerts TXG Hot Sheet
Price: $76.60 -0.48%
Rating Summary:
7 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
7 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Piper Sandler analyst David Westenberg raised the price target on 10X Genomics (NASDAQ: TXG) to $47.00 (from $42.00) while maintaining a Neutral rating.
You May Also Be Interested In
- JPMorgan Downgrades Mapletree Logistics Trust (MLT:SP) (MAPGF) to Neutral
- China Cinda Asset Management (1359:HK) PT Lowered to HK$0.95 at JPMorgan
- Dowa Holdings Co Ltd (5714:JP) PT Raised to JPY9,800 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
